⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for mucosal melanoma of the head and neck

Every month we try and update this database with for mucosal melanoma of the head and neck cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After SurgeryNCT05111574
Anal Melanoma
Bladder Melanom...
Cervical Melano...
Esophageal Mela...
Gallbladder Mel...
Mucosal Melanom...
Mucosal Melanom...
Mucosal Melanom...
Nasopharyngeal ...
Oral Cavity Muc...
Penile Mucosal ...
Rectal Melanoma
Recurrent Mucos...
Sinonasal Mucos...
Stage II Vulvar...
Stage III Vulva...
Stage IV Vulvar...
Urethral Melano...
Vaginal Melanom...
Vulvar Melanoma
Biospecimen Col...
Cabozantinib S-...
Computed Tomogr...
Echocardiograph...
Magnetic Resona...
Nivolumab
Placebo Adminis...
Positron Emissi...
18 Years - National Cancer Institute (NCI)
Nivolumab or Expectant Observation Following Ipilimumab, Nivolumab, and Surgery in Treating Patients With High Risk Localized, Locoregionally Advanced, or Recurrent Mucosal MelanomaNCT03220009
Cervical Carcin...
Esophageal Carc...
Mucosal Melanom...
Mucosal Melanom...
Oral Cavity Muc...
Recurrent Melan...
Stage II Vulvar...
Stage III Vulva...
Stage IIIA Vulv...
Stage IIIB Vulv...
Stage IIIC Vulv...
Stage IV Oral C...
Stage IV Vulvar...
Stage IVA Oral ...
Stage IVB Oral ...
Stage IVC Oral ...
Vaginal Carcino...
Conventional Su...
Ipilimumab
Laboratory Biom...
Nivolumab
Patient Observa...
Radiation Thera...
18 Years - National Cancer Institute (NCI)
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal MelanomaNCT04318717
Mucosal Melanom...
Pembrolizumab
Hypofractionate...
16 Years - Washington University School of Medicine
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: